Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Immulite IGF-1 System Assays - Various (March 13, 2013)

Starting date:
March 13, 2013
Posting date:
March 13, 2013
Type of communication:
Medical Device Recall
Subcategory:
Medical Device
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-26297

Reason

Siemens confirmed a negative bias in patient medians of approximately 5 to 20 percent using the IGF-I Assay as compared to the reference range medians provided in the IGF-I instructions for use (IFU) with kit lots released August 2008 through July 2011.

Affected products

A. Immulite 2500 System-IGF-1 (Insulin like Growth Hormone ) Assay

Lot or serial number

lots 189 to 227

Model or catalog number

L5KGF2

Companies

Manufacturer
Not Applicable



B. Immulite 2000 System-IGF-1 (Insulin like Growth Hormone ) Assay

Lot or serial number

lots 441 to 492

Model or catalog number

L2KGF2

Companies

Manufacturer
Not Applicable



C. Immulite System-IGF-1 (Insulin like Growth Hormone ) Assay

Lot or serial number

lots 315 to 335

Model or catalog number

LKGF1

Companies

Manufacturer
Not Applicable



D. Immulite 1000 System-IGF-1 (Insulin like Growth Hormone ) Assay

Lot or serial number

lots 315 to 335

Model or catalog number

LKGF1

Companies

Manufacturer
Not Applicable